The MHRA's raid follows an uptick in the trade of illegal GLP-1RA drugs used for obesity and type 2 diabetes amid shortages ...

Dupixent’s Q3 sales increased by 26.2%, breaking through the €4bn ceiling for the first time in a single quarter.

Lilly and Inctye will be seeking a label update for the JAK inhibitor for its use in paediatric patients with alopecia areata ...

Galderma becomes the latest European pharma company to heavily invest in the US this year amid pressures from President ...

EUROAPI has announced Med4Cure, an initiative within the Health Important Project of Common European Interest (IPCEI) ...

GSK has received US Food and Drug Administration (FDA) approval for Blenrep to be used along with BVd for multiple myeloma.

Roche’s CEO Thomas Schinecker said the drugmaker is continuing talks with the US government over drug pricing reforms, as ...

Immunotherapy drugs continue to gain momentum across a growing range of disease areas with blockbusters such as Merck’s ...

A report by GlobalData revealed that the biotech industry witnessed a 70.9% increase in total venture financing deal value.

Ipsen is set to purchase all issued and outstanding shares of the French biotech company ImCheck Therapeutics.

Remote monitoring technologies offer a vital option for people with diabetes to manage their conditions, with tech developed ...

Alkermes has agreed to acquire Avadel Pharmaceuticals for up to $20 per share in cash, valuing Avadel at $2.1bn. The ...